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INTRODUCTION

52
Ebolaviruses and marburgviruses are enveloped, nonsegmented, negative-53 stranded RNA viruses belonging to the family Filoviridae. These filoviruses are known 54 to cause severe hemorrhagic fever in humans and nonhuman primates with human case 55 fatality rates of up to 90% [1] . In contrast to the genus Marburgvirus, which contains only Ebola virus disease (EVD) poses a significant public health threat as implicated 62 by the increase in the incidence of EVD outbreaks in Africa over the past two decades 63 with some occurring in previously unaffected areas [3] . The most recent epidemic of EVD 64 severely affected Sierra Leone, Guinea, and Liberia, and emphasizes the need for rapid, 65 sensitive, reliable and virus-specific diagnostic tests to control the spread of the virus.
66
Rapid and simple antigen-detection tests such as immunochromatography (IC) assays 67 utilizing filovirus-specific monoclonal antibodies (mAbs) are likely one of the options for 68 early diagnosis of filovirus infections in the field setting.
69
EBOV particles consist of seven structural proteins, the nucleoprotein (NP), viral 70 protein (VP) 35, VP40, glycoprotein (GP), VP30, VP24, and polymerase [1, 4] . The NP 71 appears to be an ideal target antigen for IC assays because of its abundance in filovirus 72 particles, its strong antigenicity, and the presence of common epitopes among ebolavirus 73 species [5] . The average EBOV particle contains about 3,200 NP molecules [6] . The NP 74 plays an important role in the replication of the viral genome and is essential for formation 75 5 of the ribonucleocapsid [7] . Coexpression of NP VP40 and GP in cultured cells leads to 76 efficient production of virus-like particles (VLPs) containing NP in the core [6, 8] .
77
Previously, we generated a panel of mouse monoclonal antibodies (mAbs) 78 recognizing the EBOV NP and identified their epitopes, some of which are shared among 79 multiple ebolavirus species, whereas others are species-specific [5] . Using these mAbs,
80
we generated an IC assay (QuickNavi TM -Ebola) and evaluated its ability to detect the NP 81 antigen in culture supernatants of infected Vero E6 cells and in sera collected from EBOV- 
MATERIALS AND METHODS
86
Viruses and Cells
87
EBOV (Mayinga, Kikwit, Makona C05, and C07), SUDV (Boniface), TAFV 
Preparation of VLPs and purified recombinant NPs (rNPs)
99
Plasmids encoding NP, VP40, and GP of EBOV (Mayinga and Makona C07), 100 SUDV, TAFV, BDBV, and RESTV were constructed as described previously [5, 9] . VLPs 101 were produced by transfection of 293T cells with plasmids expressing ebolavirus NP,
102
VP40, and GP as described previously [6, 8] . Forty-eight hours after transfection, 103 supernatants containing VLPs were harvested and used for kit evaluation assays. For the 104 preparation of purified NPs, 293T cells were transfected with the plasmids expressing the
105
NPs of the respective ebolaviruses. Forty-eight hours later, the cells were lysed, and the 106 NP fraction was collected by discontinuous CsCl gradient centrifugation as described 107 previously [6, 8] . Using ZNP105-7 and ZNP108-2-5 as labeled and capturing mAbs, respectively,
162
we produced an IC device (QuickNavi TM -Ebola) (Fig. 1) . For one test, 10-30 μl of 163 samples can be applied onto the sample pad of this IC assay, followed by the addition of FFU/ml), but not SUDV, RESTV, and MARV ( Table 2 ). The spectrum of virus detection 171 was consistent with the reactivity profile of the mAbs chosen for the IC assay. To further 172 evaluate the sensitivity of the assay, we used purified rNPs and estimated that the limit of 173 the detection (LOD) ranged from 0.03 to 0.3µg/ml depending on the isolates (Table 2) .
174
Other human pathogens, including viruses and bacteria, some of which potentially cause
175
hemorrhagic fever, were also tested (Supplementary Table 1 ) but did not react in the assay.
176
In addition, we confirmed that the presence of these pathogens in human plasma did not
177
interfere with the reactivity of the IC assay to detect EBOV VLPs.
179
Application of the IC assay for EVD diagnosis 180 We next evaluated the utility of the IC assay using serum samples from 181 experimentally infected NHPs ( plaque-forming units/ml or 211 million RNA copies/ml (maximum CT value of 26.3).
246
The OraQuick Ebola, which is also based on the detection of VP40, can detect EBOV, and VP40 are 31.3 ng/ml, 3.9 ng/ml and 62.5 ng/ml, respectively. On the other hand, the
251
LODs of QuickNavi TM -Ebola were 10 3 -10 4 FFU/ml for infectious ebolaviruses and 33 252 ng/ml (1 ng/30 μl/test) for purified EBOV rNP, suggesting that our IC assay has at least 253 comparable or even better sensitivity than the above-mentioned rapid diagnostic assays.
254
It has been reported that viremia is often not detectable during the first few days concomitantly with a significant increase of viremia ( Table 3 ). Platelet counts were determined from whole blood samples. Alanine 408 aminotransferase levels (ALT) were determined from serum. The arrows indicate the time
409
at which the NHPs tested were positive in the IC assay. 
